Yippee! We have the money, page-17

Only 2 scenerios here.
1) They know efficiency results already and are lining there corporate mates pockets again
like they did last year at 70 cents with options.
2) Its a failure and they have now burned every institution and mum and dad investor.

Time will tell.
Problem for me is if they hadn't listed on the Nasdaq and announced a cure tomorrow then
you would have every biotech in the world looking at a takeover.
Go figure